Furthermore, Cyclin D1 is still necessary for the proliferation of tamoxifen-resistant breast cancer cells because small interfering RNAs (siRNAs) targeting Cyclin D1 blocked their cell growth15. Here, CCND1 is linked to breast carcinoma.